As a specialized biotechnology enterprise developing advanced antibody therapies for immunological and inflammatory diseases, Apogee competes with various clinical-stage and established biopharmaceutical firms. Primary industry rivals include major immunology-focused drug developers and large pharmaceutical corporations working on competing biologics for atopic dermatitis, asthma, and related allergic conditions.